Development of nebulized inhalation delivery for fusion-inhibitory lipopeptides to protect non-human primates against Nipah-Bangladesh infection

Reynard, O., Iampietro, M., Dumont, C., Le Guellec, S., Durand, S., Moroso, M., Brisebard, E., Dhondt, K. P., Pelissier, R., Mathieu, C., Cabrera, M., Le Pennec, D., Amurri, L., Alabi, C., Cardinaud, S., Porotto, M., Moscona, A., Vecellio, L., & Horvat, B. (2025). Development of nebulized inhalation delivery for fusion-inhibitory lipopeptides to protect non-human primates against Nipah-Bangladesh infection. Antiviral Research, 235, 106095. https://doi.org/10.1016/j.antiviral.2025.106095
Authors:
Olivier Reynard
Mathieu Iampietro
Claire Dumont
Sandrine Le Guellec
Stephanie Durand
Marie Moroso
Elise Brisebard
Kévin P Dhondt
Rodolphe Pelissier
Cyrille Mathieu
Maria Cabrera
Deborah Le Pennec
Lucia Amurri
Christopher Alabi
Sylvain Cardinaud
Matteo Porotto
Anne Moscona
Laurent Vecellio
Branka Horvat
Affiliated Authors:
Matteo Porotto
Anne Moscona
Author Keywords:
nipah virus
nebulization
virus-cell-fusion
inhibitory lipopeptides
non-human primates
antivirals
Publication Type:
Article
Unique ID:
10.1016/j.antiviral.2025.106095
PMID:
Publication Date:
Data Source:
PubMed

Record Created: